Alector (ALEC) Cash & Current Investments (2018 - 2026)
Alector (ALEC) reported Cash & Current Investments of $206.5 million for Q1 2026, down 41.75% year-over-year from $354.6 million in Q1 2025, and down 19.34% quarter-over-quarter from $256.0 million in Q4 2025.
Alector (ALEC) Cash & Current Investments (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Cash & Current Investments data on file, last reported at $206.5 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $206.5 million, down 41.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $206.5 million (down 41.75% YoY), and the FY2025 annual result was $256.0 million, down 38.07% from the prior year.
- Cash & Current Investments eased to $206.5 million in Q1 2026 per ALEC's latest filing, from $256.0 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $868.6 million in Q1 2022 and troughed at $206.5 million in Q1 2026.
- A 5-year average of $525.7 million and a median of $548.9 million in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2026: Cash & Current Investments surged 153.11% in 2022, then tumbled 41.75% in 2026.
- A 5-year view of Cash & Current Investments shows it stood at $712.9 million in 2022, then slipped by 23.0% to $548.9 million in 2023, then fell by 24.68% to $413.4 million in 2024, then sank by 38.07% to $256.0 million in 2025, then decreased by 19.34% to $206.5 million in 2026.
- Business Quant data shows ALEC's Cash & Current Investments at $206.5 million in Q1 2026, $256.0 million in Q4 2025, and $291.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 206.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206.52 Mn |
| Dec 31, 2025 | 256.02 Mn |
| Sep 30, 2025 | 291.11 Mn |
| Jun 30, 2025 | 307.28 Mn |
| Mar 31, 2025 | 354.55 Mn |
| Dec 31, 2024 | 413.40 Mn |
| Sep 30, 2024 | 457.20 Mn |
| Jun 30, 2024 | 503.33 Mn |
| Mar 31, 2024 | 562.08 Mn |
| Dec 31, 2023 | 548.86 Mn |
| Sep 30, 2023 | 588.86 Mn |
| Jun 30, 2023 | 630.05 Mn |
| Mar 31, 2023 | 669.33 Mn |
| Dec 31, 2022 | 712.85 Mn |
| Sep 30, 2022 | 758.31 Mn |
| Jun 30, 2022 | 808.86 Mn |
| Mar 31, 2022 | 868.57 Mn |
| Dec 31, 2021 | 735.25 Mn |
| Sep 30, 2021 | 777.85 Mn |
| Jun 30, 2021 | 319.57 Mn |